October 23, 2012
Cambridge, Massachusetts (United States) - Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), announces that it has been awarded a second contract to provide services to the National Institutes of Health (NIH) and certain other government agencies. This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract, has a maximum order [...]
Latest Versions of Alamut and Alamut HT Software Will Showcase at the ASHG Annual Meeting
October 23, 2012
SAN DIEGO, C.A. – Interactive Biosoftware (IBS), developer of Alamut, the world’s original mutation interpretation software, will showcase its groundbreaking Alamut 2.2 software at the internationally acclaimed American Society of Human Genetics Conference in San Francisco, CA from November 6th to November 10th. The new Alamut 2.2 upgrade is especially useful for Next Generation Sequencing [...]
Thermo Fisher Scientific Introduces Unique Extraction Workflow
October 23, 2012
BURLINGTON, ON, CANADA - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Automated Nucleic Acid Extraction WorkStation. The fully automated workflow offers consistent, high-speed purifications by combining several Thermo Fisher tools into one turnkey solution. Designed to provide cost- and time-effective nucleic acid extraction, users can process [...]
Waters Corporation Reports Third Quarter 2012 Results
October 23, 2012
MILFORD, Mass.---- Waters Corporation (NYSE: WAT) reported today third quarter 2012 sales of $450 million, a 1% decrease in comparison to sales of $455 million in the third quarter of 2011. For the quarter, foreign currency translation reduced sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the third quarter [...]
BINDER KT 115 Refrigerated Incubator Provides Accurate, Secure Conditions
October 23, 2012
BOHEMIA, N.Y. –– The new BINDER Inc. KT 115 refrigerated incubator utilizes energy-efficient, state-of-the-art Peltier refrigeration technology to provide secure, accurate control. With comprehensive program functions, the unit offers a wide range of capabilities for incubating biological materials and guarantees reproducible results. Functional chamber volume is 3.7 cu.ft. (104 liters), and the unit can run [...]
J.G. Finneran Introduces Versatility for Sample Vials
October 23, 2012
By combining a wide mouth with a tapered neck, the Versa Vial™, by J.G. Finneran Associates, simplifies the task of routinely preparing samples for autosamplers. The vase-like neck design of the Versa Vial™ has a 9mm opening, which is the largest target opening area available for any autosampler vial. With this unique design, it is [...]
Rainer Beaujean has been appointed as the new Chief Financial Officer of Gerresheimer AG
October 23, 2012
Düsseldorf, – Rainer Beaujean will join the Gerresheimer AG Management Board on December 1, 2012 and assume the function of CFO on February 1, 2013. The company’s current Chief Financial Officer, Hans-Jürgen Wiecha, is leaving the company on January 31, 2013 to pursue other career opportunities. The Supervisory Board has appointed Rainer Beaujean to the [...]
October 23, 2012
ALAMEDA, Calif -- BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading GeneCards® platform. MalaCards (www.malacards.org/) contains computerized “cards” classifying information relating to a wide array of human diseases. This novel research tool will aid researchers in studying [...]
Bioo Scientific Launches Next Generation Nucleic Acid Delivery Agent
October 23, 2012
Bioo Scientific, a world leader and innovator in the life science industry, is raising the bar for delivering nucleic acids with the release of NextFect 2012, the “Next Generation Transfection Agent”. NextFect 2012 can be used in both cell culture and in animal systems, thereby streamlining the processes of understanding cellular activity in vitro, and [...]
AREVA enters into exclusive negotiations with Astorg Partners for the sale of Canberra
October 22, 2012
AREVA and the French private equity manager Astorg Partners entered today into exclusive negotiations to finalize the project for the sale of Canberra, its nuclear measurements subsidiary. This operation is part of the "Action 2016" strategic action plan set out by AREVA in December 2011, which envisages the sale of assets with a view to [...]
